129 results
Page 6 of 7
6-K
EX-99.1
hzcl7if qhhby4u
22 Jan 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
SUPPL
kf2zz7zquvxbp0wsn
30 Nov 18
Supplemental materials (foreign)
5:23pm
6-K
EX-99.2
d78y49q
8 Nov 18
Current report (foreign)
4:04pm
6-K
EX-99.2
nelxanv0omo041
9 Aug 18
Current report (foreign)
4:05pm
6-K
EX-99.1
rpkgkskj
9 Aug 18
Aurinia Reports Second Quarter Financial Results and Operational Highlights
4:03pm
6-K
EX-99.1
hy6e4d
11 Jul 18
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome
4:01pm
6-K
EX-99.1
jzyzjs
25 Jun 18
Aurinia Initiates Clinical Trials Broadening the Development of Voclosporin
11:32am
6-K
EX-99.2
9fl u5tk98f
10 May 18
Current report (foreign)
4:06pm
6-K
EX-99.1
m9kdjip9o8ojh1b
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
zttch2n
6 Oct 16
Aurinia Releases Open-Label AURION Data Demonstrating Increased Remission Rates over Time for Voclosporin in the Treatment of Lupus Nephritis
12:00am
F-10/A
5ifg76oz6ba hh3
16 Oct 15
Registration of securities (Canada) (amended)
12:00am
6-K
EX-99.3
8nmranta
15 Aug 14
Aurinia Reports Second Quarter 2014 Financial Results
12:00am
40FR12B/A
EX-99.25
90nbe11shxqekxas1s0
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.28
3nf3xk93apfp 9j
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.50
ltz h72ufncva
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.29
oyj4tz8bfi
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.16
krceyw8u 28c
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.43
dk1lo6de
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.44
2jmxxz a4tmbldz
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.49
yvkxm0mvlga
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am